Psacalium decompositum
Psacalium decompositum · Accepted scientific name
Scientific literature: Very Sparse (6 studies) · ★☆☆☆☆
Psacalium decompositum is a medicinal plant recognized for its significant pharmacological potential in managing metabolic health. Research indicates that the root and rhizome of this species possess potent hypoglycemic and antidiabetic activities, making it a subject of interest for treating Diabetes Mellitus. These therapeutic effects are largely attributed to key chemical constituents such as cacalol, cacalol acetate, cacalone, and 3-hydroxycacalolide. Various preparations, including methanol extracts, aqueous decoctions, and fructooligosaccharides (FOS) fractions, have been studied to harness these biological benefits. Furthermore, the plant demonstrates strong antioxidant properties, contributing to its overall value in traditional and modern medicine.
- Synonyms
- Mesadenia Decomposita · Senecio Grayanus · 3 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Root · Rhizome
Classification
Common Names
Psacalium decompositum is a resilient shrub known by several different regional identifiers. It is most frequently referred to by the common name desert Indianbush. In certain areas, the plant is also widely recognized as matarique. Additionally, many people identify this species simply as maturí. These varying names reflect the diverse linguistic traditions associated with this desert plant.
Sources: Catalogue of Life (COL)
Synonyms
Psacalium decompositum is a botanical species characterized by a complex web of taxonomic synonyms. This plant has been historically identified under various names, including Cacalia decomposita and Mesadenia decomposita. Further classifications have linked it to the names Mesadenia ecomposita and Odontotrichum decompositum. It is also recognized in scientific literature as Senecio grayanus. Navigating these shifting designations is essential for researchers seeking accurate plant identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Psacalium decompositum is a unique botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, it is specifically classified under the class Equisetopsida. The plant is further organized into the order Asterales, showcasing its evolutionary connections. It holds a distinct position within the genus Psacalium, highlighting its specific morphological traits. Finally, this species is a recognized member of the diverse Asteraceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Psacalium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Psacalium decompositum is widely distributed throughout much of Northern America, spanning various ecological regions. Its range extends significantly through Mexico, including both the northeastern and northwestern territories of the country. In the United States, the species is firmly established across the South-Central region, specifically within New Mexico. It also thrives throughout the Southwestern United States, with notable populations found in Arizona. This broad geographic footprint highlights the plant's ability to adapt to diverse environments across these territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Psacalium decompositum exhibits a distinct growth form that functions as a forb within its ecosystem. This plant is entirely self-supporting, maintaining its structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Psacalium decompositum, a medicinal plant native to Mexico, has long been utilized in traditional medicine for its therapeutic potential. Scientific research confirms that the plant possesses significant antidiabetic properties, particularly through its ability to increase insulin levels. Studies have specifically highlighted its potent hypoglycemic activity, which is driven by bioactive sesquiterpenes like cacalol and cacalone. Furthermore, the plant exhibits notable antioxidant activity, offering a multi-faceted approach to managing metabolic health. These combined biological effects suggest that the species could serve as a valuable natural resource for the treatment of diabetes mellitus.
Compounds
Psacalium decompositum is a medicinal plant from Mexico that serves as a rich source of several bioactive compounds. Phytochemical analysis reveals that it contains important sesquiterpenes such as cacalol, cacalone, and cacalol acetate. Additionally, the plant is known to contain 3-hydroxycacalolide, a compound linked to its hypoglycemic properties. Beyond these sesquiterpenoids, Psacalium decompositum also contains fructooligosaccharides, which contribute to its anti-inflammatory and metabolic benefits. Together, these diverse chemical constituents support the plant's traditional use in treating diabetes and obesity.
Conditions
Psacalium decompositum treats Diabetes Mellitus through its potent hypoglycemic properties, which are driven by various sesquiterpenoids isolated from its roots and rhizomes. This medicinal plant treats the hypoglycemic effect by blocking ATP-sensitive potassium channels in a manner similar to the drug glibenclamide. Furthermore, Psacalium decompositum treats antidiabetic needs by utilizing compounds like cacalol to potentially increase insulin levels. In addition to these metabolic benefits, its derivatives like cacalol acetate treat COX-2 mRNA expression by reducing its activity and expression via the NF-κB signaling pathway. Consequently, the plant also treats COX-2 release and activity, contributing to its significant anti-inflammatory potential.
Preparations
Psacalium decompositum is prepared as a fructooligosaccharides (FOS) fraction to study its anti-inflammatory and hypolipidemic effects in obesity models. This plant is also prepared as a fructooligosaccharides fraction to investigate its potential for managing metabolic disorders. Additionally, Psacalium decompositum is prepared as methanol extracts to evaluate its in vitro nematocidal activity against specific parasites. Furthermore, the medicinal herb is prepared as a root and rhizome aqueous decoction, which has been shown to exhibit hypoglycemic effects. These various preparations allow for the identification of bioactive compounds like sesquiterpenoids that influence potassium channels.
Parts used
Psacalium decompositum is a Mexican medicinal shrub that contains significant bioactive compounds within its root and rhizome structures. Research indicates that extracts derived from the roots exhibit notable hypoglycemic effects, which may help manage blood glucose levels in various animal models. These roots also serve as a source for fructooligosaccharides that demonstrate anti-inflammatory and hypolipidemic properties beneficial for obesity control. Furthermore, specialized sesquiterpenoids, such as the novel cacalolide Romo-A, have been successfully isolated from the plant's root systems. Ultimately, the aqueous decoctions of both the root and rhizome have been experimentally shown to possess antidiabetic properties by influencing specific potassium channels.